文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期，新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

非小细胞肺癌患者第6版、第7版和第8版TNM分期的比较：第8版TNM分期的验证

Comparison of 6th, 7th, and 8th editions of the TNM staging in non-small cell lung cancer patients: Validation of the 8th edition of TNM staging.

作者信息

Erdoğu Volkan, Çıtak Necati, Sezen Celal Buğra, Aksoy Yunus, Aker Cemal, Doğru Mustafa Vedat, Emetli Ece Yasemin, Onay Selin, Saydam Özkan, Metin Muzaffer

机构信息

Department of Thoracic Surgery, Yedikule Chest Diseases and Thoracic Surgery Training and Research Hospital, Istanbul, Türkiye.

Department of Thoracic Surgery, University of Health Sciences, Bakırköy Dr. Sadi Konuk Training and Research Hospital, Istanbul, Türkiye.

出版信息

Turk Gogus Kalp Damar Cerrahisi Derg. 2022 Jul 29;30(3):395-403. doi: 10.5606/tgkdc.dergisi.2022.20089. eCollection 2022 Jul.

DOI:10.5606/tgkdc.dergisi.2022.20089
PMID:36303702
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9580290/
Abstract

BACKGROUND: In this study, we aimed to evaluate the effects of the transition from the 6 edition of the Tumor, Node, Metastasis (TNM) staging system to the 7 edition, and from the 7 edition to the 8 edition by comparing the stage migrations. We also aimed to externally validate the 8 edition of the TNM staging system. METHODS: Between September 2005 and June 2015, a total of 1,077 patients (986 males, 91 females; mean age: 59.6±8.3 years; range, 35 to 84 years) with non-small cell lung cancer who underwent lung resection were retrospectively analyzed. We re-staged patients according to 6, 7, and 8 TNM staging and compared the stage migrations of cases among the three staging systems. RESULTS: Stage migration in the transition to the 7 edition of the TNM staging system was observed in 368 (34.1%) patients whereas it was observed in 541 (50.2%) patients in the transition to the 8 edition (p<0.001). The rate of upstaging in transition to the 7 edition staging system was 50.2% (n=185), whereas it was 98.1% (n=531) for the transition to the 8 edition (p<0.001). The survival rates of Stages 1B, 2B and 3A increased with transition to the 7 edition and the survival rates of Stages 1B, 2A, 2B, 3A, and 3B increased with the transition to the 8 edition. The best stratification in the survival curves in the 6th edition was between 1B-1A and 3B-3A. In the 7 edition, it occurred between 1B-1A, 3A-2B and 3B-3A and, in the 8 edition, between 1B-1A and 3B-3A. CONCLUSION: Stratification according to the 7 edition showed better prognostic validity compared to the 6 edition; and that of the 8 edition was better compared to the 7 edition.

摘要

背景：在本研究中，我们旨在通过比较分期迁移来评估从第6版肿瘤、淋巴结、转移（TNM）分期系统向第7版，以及从第7版向第8版转变的影响。我们还旨在对第8版TNM分期系统进行外部验证。 方法：2005年9月至2015年6月期间，对1077例接受肺切除术的非小细胞肺癌患者（986例男性，91例女性；平均年龄：59.6±8.3岁；范围35至84岁）进行回顾性分析。我们根据第6、7和8版TNM分期对患者重新分期，并比较三个分期系统中病例的分期迁移情况。 结果：在向第7版TNM分期系统转变过程中，368例（34.1%）患者出现分期迁移，而在向第8版转变过程中，541例（50.2%）患者出现分期迁移（p<0.001）。向第7版分期系统转变时的分期上调率为50.2%（n=185），而向第8版转变时为98.1%（n=531）（p<0.001）。1B期、2B期和3A期的生存率随着向第7版的转变而提高，1B期、2A期、2B期、3A期和3B期的生存率随着向第8版的转变而提高。第6版生存曲线中最佳分层位于1B-1A和3B-3A之间。在第7版中，分层位于1B-1A、3A-2B和3B-3A之间，在第8版中，分层位于1B-1A和3B-3A之间。 结论：与第6版相比，第7版的分层显示出更好的预后有效性；与第7版相比，第8版的分层更好。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/937e/9580290/f3e9767157bf/TJTCS-2022-30-3-395-403-F3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/937e/9580290/27cdaf49b687/TJTCS-2022-30-3-395-403-F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/937e/9580290/c78f1a5adc4d/TJTCS-2022-30-3-395-403-F2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/937e/9580290/f3e9767157bf/TJTCS-2022-30-3-395-403-F3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/937e/9580290/27cdaf49b687/TJTCS-2022-30-3-395-403-F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/937e/9580290/c78f1a5adc4d/TJTCS-2022-30-3-395-403-F2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/937e/9580290/f3e9767157bf/TJTCS-2022-30-3-395-403-F3.jpg

相似文献

[1]
Comparison of 6th, 7th, and 8th editions of the TNM staging in non-small cell lung cancer patients: Validation of the 8th edition of TNM staging.

Turk Gogus Kalp Damar Cerrahisi Derg. 2022-7-29

[2]
Validation of the 8th edition of the TNM staging system in 3,950 patients with surgically resected non-small cell lung cancer.

J Thorac Dis. 2019-7

[3]
A comparison of the 7th and 8th editions of the AJCC staging system in terms of predicting recurrence and survival in patients with papillary thyroid carcinoma.

Oral Oncol. 2018-11-9

[4]
Stage I synchronous multiple primary non-small cell lung cancer: CT findings and the effect of TNM staging with the 7th and 8th editions on prognosis.

J Thorac Dis. 2017-12

[5]
Validation of the 8th TNM classification for small-cell lung cancer in a retrospective material from Sweden.

Lung Cancer. 2018-3-30

[6]
Comparison of staging between the old (6th edition) and new (7th edition) TNM classifications in advanced gastric cancer.

Anticancer Res. 2011-6

[7]
Comparison of the Differences in Survival Rates between the 7th and 8th Editions of the AJCC TNM Staging System for Gastric Adenocarcinoma: a Single-Institution Study of 5,507 Patients in Korea.

J Gastric Cancer. 2017-9

[8]
Validation of the 9th edition of the TNM staging system for non-small cell lung cancer with lobectomy in stage IA-IIIA.

Eur J Cardiothorac Surg. 2024-3-1

[9]
Prognostic Relevance of the Eighth Edition of TNM Classification for Resected Perihilar Cholangiocarcinoma.

J Clin Med. 2020-9-29

[10]
External Validation of the Proposed Kiel Staging System and Comparison with the Old (6th Edition) and the Currently Used (7th Edition) TNM Classification in Gastric Cancer.

Oncol Res Treat. 2018-2-27

引用本文的文献

[1]
Race, gender, and safety: exposing biases in minimally invasive lung cancer surgery research.

Transl Cancer Res. 2025-5-30

[2]
Risk analysis of visceral pleural invasion in malignant solitary pulmonary nodules that appear touching the pleural surface.

Ther Adv Respir Dis. 2024

[3]
Management of stage III non-small-cell lung cancer: rays of hope.

Explor Target Antitumor Ther. 2024

[4]
Racial disparities in staging, treatment, and mortality in non-small cell lung cancer.

Transl Lung Cancer Res. 2024-1-31

[5]
Establishment and validation of a long-term prognosis prediction model for patients with non-small cell lung cancer.

J Thorac Dis. 2023-4-28

本文引用的文献

[1]
Validation of the T descriptor in the new 8th TNM classification for non-small cell lung cancer.

J Thorac Dis. 2018-1

[2]
Cancer statistics, 2018.

CA Cancer J Clin. 2018-1-4

[3]
The IASLC Lung Cancer Staging Project: External Validation of the Revision of the TNM Stage Groupings in the Eighth Edition of the TNM Classification of Lung Cancer.

J Thorac Oncol. 2017-4-28

[4]
Lung cancer - major changes in the American Joint Committee on Cancer eighth edition cancer staging manual.

CA Cancer J Clin. 2017-1-31

[5]
The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer.

J Thorac Oncol. 2016-1

[6]
The International Association for the Study of Lung Cancer Lung Cancer Staging Project: Proposals for the Revision of the N Descriptors in the Forthcoming 8th Edition of the TNM Classification for Lung Cancer.

J Thorac Oncol. 2015-12

[7]
The IASLC Lung Cancer Staging Project: Proposals for the Revisions of the T Descriptors in the Forthcoming Eighth Edition of the TNM Classification for Lung Cancer.

J Thorac Oncol. 2015-7

[8]
Prognostic evaluation based on a new TNM staging system proposed by the International Association for the Study of Lung Cancer for resected non-small cell lung cancers.

J Thorac Cardiovasc Surg. 2008-11

[9]
The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours.

J Thorac Oncol. 2007-8

[10]
The IASLC Lung Cancer Staging Project: proposals for the revision of the T descriptors in the forthcoming (seventh) edition of the TNM classification for lung cancer.

J Thorac Oncol. 2007-7

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索